268 related articles for article (PubMed ID: 28531899)
1. Epidemiology and Molecular Biology of Head and Neck Cancer.
Jou A; Hess J
Oncol Res Treat; 2017; 40(6):328-332. PubMed ID: 28531899
[TBL] [Abstract][Full Text] [Related]
2. Human Papillomavirus-Related Head and Neck Cancer.
Wagner S; Sharma SJ; Wuerdemann N; Knuth J; Reder H; Wittekindt C; Klussmann JP
Oncol Res Treat; 2017; 40(6):334-340. PubMed ID: 28521311
[TBL] [Abstract][Full Text] [Related]
3. [Gene expression analyses and their possible clinical benefit in head and neck cancer].
Dietz A; Loeffler M; Rosolowski M; Kreuz M; Lordick F; Knödler M; Mozet C; Wichmann G
HNO; 2015 Nov; 63(11):773-85. PubMed ID: 26471186
[TBL] [Abstract][Full Text] [Related]
4.
Sailer V; Holmes EE; Gevensleben H; Goltz D; Dröge F; Franzen A; Dietrich J; Kristiansen G; Bootz F; Schröck A; Dietrich D
Clin Epigenetics; 2017; 9():12. PubMed ID: 28174607
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive genomic profiling of head and neck squamous cell carcinoma reveals FGFR1 amplifications and tumour genomic alterations burden as prognostic biomarkers of survival.
Dubot C; Bernard V; Sablin MP; Vacher S; Chemlali W; Schnitzler A; Pierron G; Ait Rais K; Bessoltane N; Jeannot E; Klijanienko J; Mariani O; Jouffroy T; Calugaru V; Hoffmann C; Lesnik M; Badois N; Berger F; Le Tourneau C; Kamal M; Bieche I
Eur J Cancer; 2018 Mar; 91():47-55. PubMed ID: 29331751
[TBL] [Abstract][Full Text] [Related]
6. MiR-21 as prognostic biomarker in head and neck squamous cell carcinoma patients undergoing an organ preservation protocol.
Arantes LM; Laus AC; Melendez ME; de Carvalho AC; Sorroche BP; De Marchi PR; Evangelista AF; Scapulatempo-Neto C; de Souza Viana L; Carvalho AL
Oncotarget; 2017 Feb; 8(6):9911-9921. PubMed ID: 28039483
[TBL] [Abstract][Full Text] [Related]
7. Telomeres and telomerase in head and neck squamous cell carcinoma: from pathogenesis to clinical implications.
Boscolo-Rizzo P; Da Mosto MC; Rampazzo E; Giunco S; Del Mistro A; Menegaldo A; Baboci L; Mantovani M; Tirelli G; De Rossi A
Cancer Metastasis Rev; 2016 Sep; 35(3):457-74. PubMed ID: 27501725
[TBL] [Abstract][Full Text] [Related]
8. Gene expression analysis of head and neck squamous cell carcinoma survival and recurrence.
Zhi X; Lamperska K; Golusinski P; Schork NJ; Luczewski L; Kolenda T; Golusinski W; Masternak MM
Oncotarget; 2015 Jan; 6(1):547-55. PubMed ID: 25575813
[TBL] [Abstract][Full Text] [Related]
9. Bioinformatics-based discovery of PYGM and TNNC2 as potential biomarkers of head and neck squamous cell carcinoma.
Jin Y; Yang Y
Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31324732
[TBL] [Abstract][Full Text] [Related]
10. TRAF3/CYLD mutations identify a distinct subset of human papillomavirus-associated head and neck squamous cell carcinoma.
Hajek M; Sewell A; Kaech S; Burtness B; Yarbrough WG; Issaeva N
Cancer; 2017 May; 123(10):1778-1790. PubMed ID: 28295222
[TBL] [Abstract][Full Text] [Related]
11. Role of miRNA in head and neck squamous cell carcinoma.
Masood Y; Kqueen CY; Rajadurai P
Expert Rev Anticancer Ther; 2015 Feb; 15(2):183-97. PubMed ID: 25367254
[TBL] [Abstract][Full Text] [Related]
12. [HPV-associated head and neck cancer : mutational signature and genomic aberrations].
Wagner S; Würdemann N; Hübbers C; Reuschenbach M; Prigge ES; Wichmann G; Hess J; Dietz A; Dürst M; Tinhofer I; von Knebel-Döberitz M; Wittekindt C; Klussmann JP
HNO; 2015 Nov; 63(11):758-67. PubMed ID: 26507715
[TBL] [Abstract][Full Text] [Related]
13. Emerging biomarkers in head and neck cancer in the era of genomics.
Kang H; Kiess A; Chung CH
Nat Rev Clin Oncol; 2015 Jan; 12(1):11-26. PubMed ID: 25403939
[TBL] [Abstract][Full Text] [Related]
14. MicroRNAs as new biomarkers for human papilloma virus related head and neck cancers.
Wang Y; Wang J; Huang Y
Cancer Biomark; 2015; 15(3):213-8. PubMed ID: 25769448
[TBL] [Abstract][Full Text] [Related]
15. SMYD2 overexpression is associated with tumor cell proliferation and a worse outcome in human papillomavirus-unrelated nonmultiple head and neck carcinomas.
Ohtomo-Oda R; Komatsu S; Mori T; Sekine S; Hirajima S; Yoshimoto S; Kanai Y; Otsuji E; Ikeda E; Tsuda H
Hum Pathol; 2016 Mar; 49():145-55. PubMed ID: 26826421
[TBL] [Abstract][Full Text] [Related]
16. Leveraging Genomics for Head and Neck Cancer Treatment.
Kemmer JD; Johnson DE; Grandis JR
J Dent Res; 2018 Jun; 97(6):603-613. PubMed ID: 29420101
[TBL] [Abstract][Full Text] [Related]
17. Cytogenetic alterations and their molecular genetic correlates in head and neck squamous cell carcinoma: a next generation window to the biology of disease.
Gollin SM
Genes Chromosomes Cancer; 2014 Dec; 53(12):972-90. PubMed ID: 25183546
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of WD repeat domain 5 associates with aggressive clinicopathological features and unfavorable prognosis in head neck squamous cell carcinoma.
Wu Y; Diao P; Li Z; Zhang W; Wang D; Wang Y; Cheng J
J Oral Pathol Med; 2018 May; 47(5):502-510. PubMed ID: 29569374
[TBL] [Abstract][Full Text] [Related]
19. Non coding RNAs in head and neck squamous cell carcinoma (HNSCC): a clinical perspective.
Denaro N; Merlano MC; Russi EG; Lo Nigro C
Anticancer Res; 2014 Dec; 34(12):6887-96. PubMed ID: 25503114
[TBL] [Abstract][Full Text] [Related]
20. Aberrant methylation inactivates somatostatin and somatostatin receptor type 1 in head and neck squamous cell carcinoma.
Misawa K; Misawa Y; Kondo H; Mochizuki D; Imai A; Fukushima H; Uehara T; Kanazawa T; Mineta H
PLoS One; 2015; 10(3):e0118588. PubMed ID: 25734919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
